NCT04916002 2025-12-05
A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer
Regeneron Pharmaceuticals
Phase 2 Terminated
Regeneron Pharmaceuticals
ImmunityBio, Inc.
ImmunityBio, Inc.
Dana-Farber Cancer Institute
Stanford University
Philogen S.p.A.